HIV–related malignancies, viral oncogenesis
The HIV and AIDS Malignancy Branch (HAMB), Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), is a national leader in research in the cancers associated with HIV/AIDS, in the development of therapies for HIV infection, and in oncogenic viruses. We are seeking a tenure-eligible or tenure-track investigator in the field of HIV–related malignancies or viral oncogenesis. It is anticipated that the investigator will establish an independent translational research program targeted to the study of the treatment, pathogenesis, and/or prevention of viral-induced or other HIV-associated tumors. The program can be primarily clinical, laboratory-based, or a combination of the two, and can also include animal model studies. There is the potential to interface with a strong existing clinical research program. Potential areas of focus may include, but are not limited to, therapies for HIV malignancies, including novel immunologic approaches; viral oncogenesis; pathogenesis of HIV-associated malignancies; and virus host interactions, including immunologic interactions.
Applicants must have a Ph.D., M.D., M.D./Ph.D. or equivalent degree and strong research credentials.
The CCR is the largest intramural component of the NCI. CCR investigators have access to the Clinical Center, the largest hospital in the world devoted exclusively to clinical research. HAMB was founded in 1996 to bring together researchers in the NCI working on the areas of HIV/AIDS-related malignancy, viruses associated with HIV malignancy, and HIV drug development. Its researchers have made a number of key contributions and have developed important therapies for HIV and HIV malignancies. Clinical research activities involve patients with Kaposi sarcoma, multicentric Castleman disease, central nervous system lymphoma, primary effusion lymphoma, and a variety of other HIV-associated tumors. The Branch has many collaborative laboratory and clinical research projects that include studies related to Kaposi sarcoma-associated herpes virus (KSHV), HIV, and assessment of checkpoint inhibitors and other immunologic therapies in HIV patients.
Applicants for this position should submit a curriculum vitae including complete bibliography, a statement of research interests, a two-page outline of the proposed research program, and the names and addresses of three references. Applicants will be notified before references are contacted. Salary is competitive and commensurate with research experience and accomplishments. A full civil service package of benefits (including health insurance, life insurance, and retirement) is available. Applications must be submitted electronically to https://irp-positions.nih.gov/job/HAMB. This position is not restricted to U.S. citizens. NIH is dedicated to building a diverse community in its training and employment programs. This position will remain open until filled with the review of applications to begin on or about December 15, 2017.
HHS, NIH, and NCI are Equal Opportunity Employers